Gyno-Pevaryl (Econazole Nitrate)

Gyno-Pevaryl is indicated for the treatment of vaginal candidiasis, a common yeast infection caused by Candida species.

• Treatment of acute vaginal yeast infection caused by Candida albicans.
• Management of recurrent vaginal candidiasis under medical supervision.
• Adjunct therapy for mixed infections where a fungal component is identified.
• Use in patients who require a topical antifungal with a low systemic absorption profile.
• Treatment of vulvovaginal itching and discharge associated with confirmed fungal etiology.
• Prophylactic application after antibiotic therapy when risk of yeast overgrowth is high, as directed by a healthcare professional.

Side effects reported with vaginal econazole nitrate products are generally mild, reflecting local exposure, but rare serious reactions can occur.

Common

• Local irritation or burning sensation at the application site.
• Mild itching or redness of the vulvar skin.
• Vaginal discharge with a slight odor.
• Slight swelling or edema of the vaginal mucosa.
• Unusual vaginal bleeding.
• Sensation of pressure or fullness in the pelvis.

Serious

• Allergic reaction such as urticaria, angioedema, or anaphylaxis.
• Severe dermatitis or contact eczema extending beyond the application area.
• Persistent or worsening symptoms suggesting secondary infection.

When using Gyno-Pevaryl, certain precautions help ensure safe and effective treatment and reduce the risk of complications.

• Confirm diagnosis of Candida infection before initiating therapy.
• Avoid use if there is known hypersensitivity to econazole or other imidazole antifungals.
• Do not apply the product on inflamed, ulcerated, or broken skin.
• Use the product for the prescribed duration; premature discontinuation may lead to recurrence.
• Discuss use with a healthcare provider during pregnancy, lactation, or if planning conception.
• Keep the product out of reach of children and store according to label instructions.

Econazole nitrate may interact with other topical agents or systemic medications that affect fungal flora or liver metabolism.

Avoid

• Concurrent use of other vaginal antifungal preparations without medical advice.
• Application together with spermicidal products that may irritate mucosa.

Use with caution

• Use with systemic azole antifungals (e.g., fluconazole) as combined exposure may increase systemic absorption.
• Co‑administration with estrogen‑containing vaginal tablets may alter local pH and affect efficacy.
• Patients on hepatotoxic drugs should be monitored, although systemic exposure from vaginal use is minimal.